Cargando…

Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

The need for new acid suppressing agents with improved pharmacology and superior antisecretory effects to address unmet clinical needs in acid-related disorders has been evident for over a decade. Recent new antisecretory drugs (IR-omeprazole and MR-dexlansoprazole) only provide a small incremental...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunt, Richard H, Scarpignato, Carmelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816037/
https://www.ncbi.nlm.nih.gov/pubmed/26513137
http://dx.doi.org/10.1038/ctg.2015.39